Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04922242 · ClinicalTrials.gov registry record · NA
Welch Emotional Connection Screen (WECS) in the NICU
A NA study of Premature Birth and Obstetric Labor, Premature, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
- 1
- Study location
NCT04922242: Completed NA study of Premature Birth and Obstetric Labor, Premature, sponsored by Columbia University.
NCT04922242 is a NA study of Premature Birth and Obstetric Labor, Premature that has completed, run by Columbia University. The registered enrollment target is 193 participants, below the 389-participant average among 38 other Premature Birth trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04922242, a NA study of Premature Birth and Obstetric Labor, Premature, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess knowledge about emotional connection, attitude about relational health, and efficacy of Welch Emotional Connection Screen (WECS) training in the NICU. The investigators seek to discern if through this didactic training, frontline NICU clinicians can be taught to reliably use the WECS to rate parent-child relational health. Additionally, the investigators seek to learn if there is construct and theoretical validity of the hospitalized infant preterm WECS by correlating WECS scores to physiological, behavioral and mental health markers for parent and infant.
Primary Outcome
Assess staff opinions of NICU WECS using focus groups. Responses will be coded utilizing a grounded theory hypothesis to find thematic evidence to assess the feasibility, utility, acceptability, and efficacy of the WECS in clinical practice.
Conditions Studied
Interventions
- BEHAVIORAL Welch Emotional Connection Screen for Neonatal Intensive Care Unit
- OTHER NICU WECS Training
Study Locations (1)
New Jersey
- The Valley Hospital - Ridgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2021-04-17 |
| Est. Completion | 2023-02-13 |
| Phase | NA |
What the finished NCT04922242 record still lists
NCT04922242 is an interventional study that assigns participants to a tested intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap, below the 389-participant average among 38 other Premature Birth trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Premature Birth appearing as the primary indexed condition, and to 2 interventions - of which Welch Emotional Connection Screen for Neonatal Intensive Care Unit is the first listed.
NCT04922242 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04922242 about?
NCT04922242 is a clinical study titled "Welch Emotional Connection Screen (WECS) in the NICU". The purpose of this study is to assess knowledge about emotional connection, attitude about relational health, and efficacy of Welch Emotional Connection Screen (WECS) training in the NICU. The investigators seek to discern if through this didactic training, frontline NICU clinicians can be taught t...
What is the current status of trial NCT04922242?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2021-04-17. Estimated completion is 2023-02-13.
What conditions does trial NCT04922242 study?
This clinical trial studies the following conditions: Premature Birth, Obstetric Labor, Premature.
What interventions are being tested in trial NCT04922242?
The interventions under investigation include: Welch Emotional Connection Screen for Neonatal Intensive Care Unit (BEHAVIORAL), NICU WECS Training (OTHER).
Who is sponsoring clinical trial NCT04922242?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04922242 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04922242's enrollment target sits among peer trials
193 15th of 38 higher than 24 of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
-
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI